Trade Secret Status Triggers Marketing Exclusivity For Chinese Drug Manufacturer
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - A traditional medicine used to treat osteoporosis has been declared a technological secret by the Chinese government, providing the Tongjitang Chinese Medicine Company with five years of marketing exclusivity under State Food and Drug Administration rules